Cargando…
Engineering of GlcNAc-1-Phosphotransferase for Production of Highly Phosphorylated Lysosomal Enzymes for Enzyme Replacement Therapy
Several lysosomal enzymes currently used for enzyme replacement therapy in patients with lysosomal storage diseases contain very low levels of mannose 6-phosphate, limiting their uptake via mannose 6-phosphate receptors on the surface of the deficient cells. These enzymes are produced at high levels...
Autores principales: | Liu, Lin, Lee, Wang-Sik, Doray, Balraj, Kornfeld, Stuart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415318/ https://www.ncbi.nlm.nih.gov/pubmed/28480305 http://dx.doi.org/10.1016/j.omtm.2017.03.006 |
Ejemplares similares
-
Structures of the mannose-6-phosphate pathway enzyme, GlcNAc-1-phosphotransferase
por: Gorelik, Alexei, et al.
Publicado: (2022) -
Structural insights into how GlcNAc-1-phosphotransferase directs lysosomal protein transport
por: Du, Shuo, et al.
Publicado: (2022) -
Enzyme-based assay for quantification of UDP-GlcNAc in cells and tissues
por: Chatham, John C., et al.
Publicado: (2023) -
Biosynthesis of UDP-GlcNAc, UndPP-GlcNAc and UDP-GlcNAcA Involves Three Easily Distinguished 4-Epimerase Enzymes, Gne, Gnu and GnaB
por: Cunneen, Monica M., et al.
Publicado: (2013) -
Inactivation of the three GGA genes in HeLa cells partially compromises lysosomal enzyme sorting
por: Doray, Balraj, et al.
Publicado: (2021)